Evolution of carbapenem resistance in Acinetobacter baumannii: An 18-year longitudinal study from a medical center innorthern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 1, 2015, Pages 57-64

  Ku, Wen Wei ^a   Kung, Che Hsuang ^a   Lee, Chi Hung ^a   Tseng, Chih Peng ^b   Wu, Ping Feng ^a   Kuo, Shu Chen ^c,d   Chen, Te Li ^d   Lee, Yi Tzu ^a,d   Wang, Fu Der ^a,d   Fung, Chang Phone ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

ISAba1 blaOXA 23 like; ISAba1 blaOXA 51 like; Tn2006; Tn2008

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAM; CARBAPENEM; CARBAPENEMASE; CIPROFLOXACIN; COLISTIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; TRANSPOSON;

ACINETOBACTER BAUMANNII; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHDL GENE; CONTROLLED STUDY; LONGITUDINAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; TRANSPOSON; ACINETOBACTER INFECTIONS; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DRUG EFFECTS; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PREVALENCE; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PREVALENCE; TAIWAN;

EID: 84921386031     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.07.005     Document Type: Article

References (36)

1. Chen S.J., Chao T.F., Chiang M.C., Kuo S.C., Chen L.Y., Chiang D.H., et al. Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2011, 44:209-214.
2. Chiang M.C., Kuo S.C., Chen Y.C., Lee Y.T., Chen T.L., Fung C.P. Polymerase chain reaction assay for the detection of Acinetobacter baumannii in endotracheal aspirates from patients in the intensive care unit. J Microbiol Immunol Infect 2011, 44:106-110.
3. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
4. Kuo S.C., Chang S.C., Wang H.Y., Lai J.F., Chen P.C., Shiau Y.R., et al. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infectious Dis 2012, 12:200.
5. Chen L.Y., Kuo S.C., Liu C.Y., Luo B.S., Huang L.J., Lee Y.T., et al. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. J Microbiol Immunol Infect 2011, 44:358-363.
6. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
7. Walther-Rasmussen J., Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006, 57:373-383.
8. Paton R., Miles R.S., Hood J., Amyes S.G., Miles R.S., Amyes S.G. ARI-1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993, 2:81-88.
9. Brown S., Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 2006, 57:1-3.
10. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:2573-2580.
11. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-nonsusceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
12. OXA-23 from hospitals in central Taiwan. J Microbiol Immunol Infect 2013, 46:419-424.
13. Lee Y.T., Fung C.P., Wang F.D., Chen C.P., Chen T.L., Cho W.L. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit. J Microbiol Immunol Infect 2012, 45:43-51.
14. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
15. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005, 43:1632-1639.
16. Huang L.Y., Chen T.L., Lu P.L., Tsai C.A., Cho W.L., Chang F.Y., et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008, 14:1010-1019.
17. Ejrnaes K., Sandvang D., Lundgren B., Ferry S., Holm S., Monsen T., et al. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J Clin Microbiol 2006, 44:1776-1781.
18. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. CLSI document 2012, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA, M100-MS22.
19. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
20. Higgins P.G., Lehmann M., Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010, 35:305.
21. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
22. GIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother 2004, 48:4654-4661.
23. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005, 49:4485-4491.
24. Lu P.L., Huang L.Y., Lian S.T., Chang K., Lin C.L., Hwang I.J., et al. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int J Antimicrob Agents 2008, 31:463-466.
25. Pasteran F., Rapoport M., Petroni A., Faccone D., Corso A., Galas M., et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006, 50:3222-3224.
26. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:1530-1533.
27. Lee C.M., Lai C.C., Wang Y.Y., Lee M.C., Hsueh P.R. Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010. Diagn Microbiol Infect Dis 2013, 75:94-100.
28. Chuang Y.-C., Sheng W.-H., Lauderdale T.-L., Li S.-Y., Wang J.-T., Chen Y.-C., et al. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J Microbiol Immunol Infect 2014, 47:324-332.
29. Koh T.H., Sng L.H., Wang G.C.Y., Hsu L.Y., Zhao Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2007, 59:627-632.
30. Zhou H., Yang Q., Yu Y.S., Wei Z.Q., Li L.J. Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China. J Clin Microbiol 2007, 45:4054-4057.
31. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol 2005, 43:2241-2245.
32. Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009, 63:55-59.
33. Lee H.Y., Chang R.C., Su L.H., Liu S.Y., Wu S.R., Chuang C.H., et al. Wide spread of Tn2006 in an AbaR4-type resistance island amongcarbapenem-resistant Acinetobacter baumannii clinicalisolates in Taiwan. Int J Antimicrob Agents. 2012, 40(2):163-167.
34. OXA-23 carbapenemase gene of. Acinetobacter baumannii. Emerg Infect Dis 2010, 16:35-40.
35. Cao J., Song W., Gu B., Mei Y.N., Tang J.P., Meng L., et al. Correlation between carbapenem consumption and antimicrobial resistance rates of Acinetobacter baumannii in a university-affiliated hospital in China. J Clin Pharmacol 2013, 53:96-102.
36. Lee Y.T., Kuo S.C., Yang S.P., Lin Y.T., Tseng F.C., Chen T.L., et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis. 2012, 55:209-215.